This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Aberdeen Asset Management | Jefferies cuts TP to 440p from 475p, Hold |
| Ashmore Group | Jefferies cuts TP to 475p from 490p, Buy |
| Bovis Homes | Jefferies ups TP to 909p from 897p, Buy |
| F&C Asset Management | Jefferies cuts TP to 130p from 135p, Buy |
| Hargreaves Lansdown | Jefferies cuts TP to 1050p from 1150p, Buy |
| Jupiter Fund Management | Jefferies cuts TP to 330p from 340p, Hold |
| MAN Group | Jefferies cuts TP to 65p from 75p, underperform |
| Polymetal International | HSBC cuts TP to 620p from 1000p, overweight |
| Synergy Health | Investec downgrades to add from Buy |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research